151 related articles for article (PubMed ID: 23151632)
1. Structural insights into the specific anti-HIV property of actinohivin: structure of its complex with the α(1-2)mannobiose moiety of gp120.
Hoque MM; Suzuki K; Tsunoda M; Jiang J; Zhang F; Takahashi A; Ohbayashi N; Zhang X; Tanaka H; Omura S; Takénaka A
Acta Crystallogr D Biol Crystallogr; 2012 Dec; 68(Pt 12):1671-9. PubMed ID: 23151632
[TBL] [Abstract][Full Text] [Related]
2. The characteristic structure of anti-HIV actinohivin in complex with three HMTG D1 chains of HIV-gp120.
Zhang F; Hoque MM; Jiang J; Suzuki K; Tsunoda M; Takeda Y; Ito Y; Kawai G; Tanaka H; Takénaka A
Chembiochem; 2014 Dec; 15(18):2766-73. PubMed ID: 25403811
[TBL] [Abstract][Full Text] [Related]
3. Mechanism by which the lectin actinohivin blocks HIV infection of target cells.
Tanaka H; Chiba H; Inokoshi J; Kuno A; Sugai T; Takahashi A; Ito Y; Tsunoda M; Suzuki K; Takénaka A; Sekiguchi T; Umeyama H; Hirabayashi J; Omura S
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15633-8. PubMed ID: 19717426
[TBL] [Abstract][Full Text] [Related]
4. Actinohivin: specific amino acid residues essential for anti-HIV activity.
Takahashi A; Inokoshi J; Tsunoda M; Suzuki K; Takenaka A; Sekiguchi T; Omura S; Tanaka H
J Antibiot (Tokyo); 2010 Nov; 63(11):661-5. PubMed ID: 20842142
[TBL] [Abstract][Full Text] [Related]
5. Crystallographic study of the interaction of the anti-HIV lectin actinohivin with the α(1-2)mannobiose moiety of gp120 HMTG.
Suzuki K; Ohbayashi N; Jiang J; Zhang X; Hoque MM; Tsunoda M; Murayama K; Tanaka H; Takénaka A
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Sep; 68(Pt 9):1060-3. PubMed ID: 22949194
[TBL] [Abstract][Full Text] [Related]
6. Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120.
Chiba H; Inokoshi J; Nakashima H; Omura S; Tanaka H
Biochem Biophys Res Commun; 2004 Mar; 316(1):203-10. PubMed ID: 15003531
[TBL] [Abstract][Full Text] [Related]
7. Peculiarity in crystal packing of anti-HIV lectin actinohivin in complex with α(1-2)mannobiose.
Suzuki K; Tsunoda M; Hoque MM; Zhang F; Jiang J; Zhang X; Ohbayashi N; Tanaka H; Takénaka A
Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1818-25. PubMed ID: 23999305
[TBL] [Abstract][Full Text] [Related]
8. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
[TBL] [Abstract][Full Text] [Related]
9. The high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-HIV activity.
Takahashi A; Inokoshi J; Hachiya A; Oka S; Omura S; Tanaka H
J Antibiot (Tokyo); 2011 Aug; 64(8):551-7. PubMed ID: 21694730
[TBL] [Abstract][Full Text] [Related]
10. Essential regions for antiviral activities of actinohivin, a sugar-binding anti-human immunodeficiency virus protein from an actinomycete.
Takahashi A; Inokoshi J; Chiba H; Omura S; Tanaka H
Arch Biochem Biophys; 2005 May; 437(2):233-40. PubMed ID: 15850563
[TBL] [Abstract][Full Text] [Related]
11. Burkholderia oklahomensis agglutinin is a canonical two-domain OAA-family lectin: structures, carbohydrate binding and anti-HIV activity.
Whitley MJ; Furey W; Kollipara S; Gronenborn AM
FEBS J; 2013 May; 280(9):2056-67. PubMed ID: 23480609
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120.
Bewley CA
Structure; 2001 Oct; 9(10):931-40. PubMed ID: 11591348
[TBL] [Abstract][Full Text] [Related]
13. Solution and crystal molecular dynamics simulation study of m4-cyanovirin-N mutants complexed with di-mannose.
Vorontsov II; Miyashita O
Biophys J; 2009 Nov; 97(9):2532-40. PubMed ID: 19883596
[TBL] [Abstract][Full Text] [Related]
14. Anti-HIV-1 activity of a tripodal receptor that recognizes mannose oligomers.
Rivero-Buceta E; Carrero P; Casanova E; Doyagüez EG; Madrona A; Quesada E; Peréz-Pérez MJ; Mateos R; Bravo L; Mathys L; Noppen S; Kiselev E; Marchand C; Pommier Y; Liekens S; Balzarini J; Camarasa MJ; San-Félix A
Eur J Med Chem; 2015 Dec; 106():132-43. PubMed ID: 26540494
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of the HIV-1 inhibitory cyanobacterial protein MVL free and bound to Man3GlcNAc2: structural basis for specificity and high-affinity binding to the core pentasaccharide from n-linked oligomannoside.
Williams DC; Lee JY; Cai M; Bewley CA; Clore GM
J Biol Chem; 2005 Aug; 280(32):29269-76. PubMed ID: 15937331
[TBL] [Abstract][Full Text] [Related]
16. The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120.
Bewley CA; Otero-Quintero S
J Am Chem Soc; 2001 May; 123(17):3892-902. PubMed ID: 11457139
[TBL] [Abstract][Full Text] [Related]
17. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
Barrientos LG; Matei E; Lasala F; Delgado R; Gronenborn AM
Protein Eng Des Sel; 2006 Dec; 19(12):525-35. PubMed ID: 17012344
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist.
Courter JR; Madani N; Sodroski J; Schön A; Freire E; Kwong PD; Hendrickson WA; Chaiken IM; LaLonde JM; Smith AB
Acc Chem Res; 2014 Apr; 47(4):1228-37. PubMed ID: 24502450
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of the monovalent lectin microvirin in complex with Man(alpha)(1-2)Man provides a basis for anti-HIV activity with low toxicity.
Shahzad-ul-Hussan S; Gustchina E; Ghirlando R; Clore GM; Bewley CA
J Biol Chem; 2011 Jun; 286(23):20788-96. PubMed ID: 21471192
[TBL] [Abstract][Full Text] [Related]
20. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.
Scanlan CN; Pantophlet R; Wormald MR; Ollmann Saphire E; Stanfield R; Wilson IA; Katinger H; Dwek RA; Rudd PM; Burton DR
J Virol; 2002 Jul; 76(14):7306-21. PubMed ID: 12072529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
